According to a recent LinkedIn post from Gardin, the company’s technology was evaluated by Plant Lighting B.V. for its ability to detect a key physiological transition in Phalaenopsis orchids. The trial compared Gardin’s sensing platform with the LI-COR LI-6800 system to identify the shift from CAM Phase III to Phase IV, a point at which the plant’s response to light changes.
The post suggests that Gardin’s system detected this CAM III to IV transition at the same time as the LI-COR reference instrument. This capability is positioned as potentially useful for greenhouse growers seeking to optimize the duration of supplemental lighting based on real-time plant responses.
From an investor perspective, this validation against an established scientific tool may indicate growing technical credibility for Gardin’s agtech platform. If growers adopt such data-driven lighting control, Gardin could benefit from recurring revenue opportunities in high-value greenhouse crops and potentially improved pricing power tied to energy savings and yield optimization.
The case study focus on orchids also points to Gardin’s relevance in specialized horticulture segments where margins can justify investment in advanced monitoring. Broader industry adoption would depend on scalability, integration into greenhouse workflows, and demonstrable cost-benefit outcomes, factors that investors may track as indicators of commercial traction.


